Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias.

Stella S, Gottardi EM, Favout V, Barragan Gonzalez E, Errichiello S, Vitale SR, Fava C, Luciano L, Stagno F, Grimaldi F, Pironi L, Sargas Simarro C, Vigneri P, Izzo B.

Int J Mol Sci. 2019 Dec 4;20(24). pii: E6106. doi: 10.3390/ijms20246106.

2.

In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent.

Baccarani M, Iacobucci I, Chiaretti S, Foà' R, Balasubramanian P, Paietta E, Foroni L, Jeromin S, Izzo B, Spinelli O, Varma N, Menif S, Terragna C, Seth T, Bidet A, Coriu D, Lunghi F, Mayer J, Scappini B, Langabeer S, Maier J, Burt E, Candoni A, Albano F, Luppi M, Zupan I, Lion T, Zadro R, di Raimondo F, Poopak B, Rege-Cambrin G, Annunziata M, Ayala A, Salinas-Viedma V, Ines Prado A, Milner B, Galimberti S, Janssen J, Polli V, Comba L, Borsellino B, Annibali O, Crugnola M, Passamonti F.

Leukemia. 2019 Oct 8. doi: 10.1038/s41375-019-0591-9. [Epub ahead of print] No abstract available.

PMID:
31595038
3.

Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches.

Izzo B, Gottardi EM, Errichiello S, Daraio F, Baratè C, Galimberti S.

Front Oncol. 2019 Sep 6;9:833. doi: 10.3389/fonc.2019.00833. eCollection 2019. Review.

4.

Laboratory medicine: health evaluation in elite athletes.

Lombardo B, Izzo V, Terracciano D, Ranieri A, Mazzaccara C, Fimiani F, Cesaro A, Gentile L, Leggiero E, Pero R, Izzo B, D'Alicandro AC, Ercolini D, D'Alicandro G, Frisso G, Pastore L, Calabrò P, Scudiero O.

Clin Chem Lab Med. 2019 Sep 25;57(10):1450-1473. doi: 10.1515/cclm-2018-1107. Review.

PMID:
30835249
5.

Ectopic Liver Tissue Presenting as a Right Atrial Mass on Echocardiography.

Izzo BA, Stoudenmire CJ, Byrd BF 3rd.

CASE (Phila). 2017 Aug 3;1(6):212-215. doi: 10.1016/j.case.2017.05.007. eCollection 2017 Dec. No abstract available.

6.

Relationship between early administration of abciximab and TIMI flow in STEMI patients undergoing primary angioplasty: findings from a large regional STEMI network.

Izzo A, Rosiello R, Lucchini G, Tomasi L, Mantovani P, Lettieri C, Baccaglioni N, Romano M, Buffoli F, Izzo B, Zanini R.

J Cardiovasc Med (Hagerstown). 2017 Jun;18(6):398-403. doi: 10.2459/JCM.0000000000000426.

PMID:
27454650
7.

Use of decision aids for shared decision making in venous thromboembolism: A systematic review.

Barnes GD, Izzo B, Conte ML, Chopra V, Holbrook A, Fagerlin A.

Thromb Res. 2016 Jul;143:71-5. doi: 10.1016/j.thromres.2016.05.009. Epub 2016 May 12. Review.

PMID:
27203185
8.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Cross NC, White HE, Ernst T, Welden L, Dietz C, Saglio G, Mahon FX, Wong CC, Zheng D, Wong S, Wang SS, Akiki S, Albano F, Andrikovics H, Anwar J, Balatzenko G, Bendit I, Beveridge J, Boeckx N, Cerveira N, Cheng SM, Colomer D, Czurda S, Daraio F, Dulucq S, Eggen L, El Housni H, Gerrard G, Gniot M, Izzo B, Jacquin D, Janssen JJ, Jeromin S, Jurcek T, Kim DW, Machova-Polakova K, Martinez-Lopez J, McBean M, Mesanovic S, Mitterbauer-Hohendanner G, Mobtaker H, Mozziconacci MJ, Pajič T, Pallisgaard N, Panagiotidis P, Press RD, Qin YZ, Radich J, Sacha T, Touloumenidou T, Waits P, Wilkinson E, Zadro R, Müller MC, Hochhaus A, Branford S.

Leukemia. 2016 Sep;30(9):1844-52. doi: 10.1038/leu.2016.90. Epub 2016 Apr 25.

9.

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.

Cross NC, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E, Lange T, Lion T, Machova Polakova K, Dulucq S, Martinelli G, Oppliger Leibundgut E, Pallisgaard N, Barbany G, Sacha T, Talmaci R, Izzo B, Saglio G, Pane F, Müller MC, Hochhaus A.

Leukemia. 2015 May;29(5):999-1003. doi: 10.1038/leu.2015.29. Epub 2015 Feb 5. Review.

10.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikienė E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedéu J, Nymoen DA, Leibundgut EO, Ozbek U, Pajič T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VH, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Müller MC, Hochhaus A, Schimmel H, Cross NC, Emons H.

Leukemia. 2015 Feb;29(2):369-76. doi: 10.1038/leu.2014.217. Epub 2014 Jul 18.

11.

Molecular analysis of cluster headache.

Zarrilli F, Tomaiuolo R, Ceglia C, Lombardo B, Izzo B, Castaldo G, Pastore L, De Simone R.

Clin J Pain. 2015 Jan;31(1):52-7. doi: 10.1097/AJP.0000000000000075.

PMID:
24469609
12.

In reply.

Mirza A, Mirza JB, Shin AY, Lorenzana DJ, Lee BK, Izzo B.

J Hand Surg Am. 2013 Dec;38(12):2519. doi: 10.1016/j.jhsa.2013.09.030. No abstract available.

PMID:
24275057
13.

Isolated lunotriquetral ligament tears treated with ulnar shortening osteotomy.

Mirza A, Mirza JB, Shin AY, Lorenzana DJ, Lee BK, Izzo B.

J Hand Surg Am. 2013 Aug;38(8):1492-7. doi: 10.1016/j.jhsa.2013.05.024. Epub 2013 Jul 9.

PMID:
23849735
14.

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss T, Izzo B, Nomdedeu J, van der Heijden A, van der Reijden BA, Jansen JH, van der Velden VH, Ommen H, Preudhomme C, Saglio G, Grimwade D.

J Clin Oncol. 2009 Nov 1;27(31):5195-201. doi: 10.1200/JCO.2009.22.4865. Epub 2009 Sep 14.

PMID:
19752335
15.

Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia.

Lo-Coco F, Cuneo A, Pane F, Cilloni D, Diverio D, Mancini M, Testoni N, Bardi A, Izzo B, Bolli N, La Starza R, Fazi P, Iacobelli S, Piciocchi A, Vignetti M, Amadori S, Mandelli F, Pelicci PG, Mecucci C, Falini B, Saglio G; Acute Leukemia Working Party of the GIMEMA group.

Haematologica. 2008 Jul;93(7):1017-24. doi: 10.3324/haematol.12004. Epub 2008 May 27.

16.

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate.

Alimena G, Breccia M, Luciano L, Quarantelli F, Diverio D, Izzo B, De Angelis B, Mancini M, Latagliata R, Carmosino I, Nanni M, Picardi M, Rotoli B, Mandelli F, Pane F.

Leuk Res. 2008 Feb;32(2):255-61. Epub 2007 Aug 10.

PMID:
17692911
17.

Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.

Soverini S, Colarossi S, Gnani A, Rosti G, Castagnetti F, Poerio A, Iacobucci I, Amabile M, Abruzzese E, Orlandi E, Radaelli F, Ciccone F, Tiribelli M, di Lorenzo R, Caracciolo C, Izzo B, Pane F, Saglio G, Baccarani M, Martinelli G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Clin Cancer Res. 2006 Dec 15;12(24):7374-9.

18.

Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.

Palmieri S, Ferrara F, Leoni F, Ciolli S, Pollio F, D'Amico MR, Celentano M, Viola A, Vicari L, Izzo B, Pane F.

Hematol Oncol. 2007 Mar;25(1):1-5.

PMID:
17036374
19.

Presence of FLT3 mutations does not impair stem cell mobilization and feasibility of autologous peripheral blood stem cell transplantation in acute myeloid leukemia.

Ferrara F, Palmieri S, Pollio F, Lo Pardo C, Graziano D, Celentano M, D'Amico MR, Vicari L, Izzo B, Pane F.

Biol Blood Marrow Transplant. 2006 Sep;12(9):981-6.

20.

Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.

Iacobucci I, Saglio G, Rosti G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Merante S, Frassoni F, Paolini S, Montefusco E, Baccarani M, Martinelli G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Clin Cancer Res. 2006 May 15;12(10):3037-42.

21.

Endocrine and ultrasonographic aspects of the oestrous cycle of the mule.

Volpe P, Russo M, Ianetti L, Izzo B.

Vet Rec. 2005 Dec 3;157(23):740-4.

PMID:
16326968
22.

ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.

Soverini S, Martinelli G, Rosti G, Bassi S, Amabile M, Poerio A, Giannini B, Trabacchi E, Castagnetti F, Testoni N, Luatti S, de Vivo A, Cilloni D, Izzo B, Fava M, Abruzzese E, Alberti D, Pane F, Saglio G, Baccarani M.

J Clin Oncol. 2005 Jun 20;23(18):4100-9. Epub 2005 May 2.

PMID:
15867198
23.

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.

Pane F, Cimino G, Izzo B, Camera A, Vitale A, Quintarelli C, Picardi M, Specchia G, Mancini M, Cuneo A, Mecucci C, Martinelli G, Saglio G, Rotoli B, Mandelli F, Salvatore F, Foà R; GIMEMA group.

Leukemia. 2005 Apr;19(4):628-35.

PMID:
15744351
24.

Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.

Baccarani M, Martinelli G, Rosti G, Trabacchi E, Testoni N, Bassi S, Amabile M, Soverini S, Castagnetti F, Cilloni D, Izzo B, de Vivo A, Messa E, Bonifazi F, Poerio A, Luatti S, Giugliano E, Alberti D, Fincato G, Russo D, Pane F, Saglio G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Blood. 2004 Dec 15;104(13):4245-51. Epub 2004 Aug 19.

PMID:
15319292
25.

Molecular response to imatinib in late chronic-phase chronic myeloid leukemia.

Rosti G, Martinelli G, Bassi S, Amabile M, Trabacchi E, Giannini B, Cilloni D, Izzo B, De Vivo A, Testoni N, Cambrin GR, Bonifazi F, Soverini S, Luatti S, Gottardi E, Alberti D, Pane F, Salvatore F, Saglio G, Baccarani M; Study Committee, Italian Cooperative Study Group for Chronic Myeloid Leukemia; Writing Committee, Italian Cooperative Study Group for Chronic Myeloid Leukemia.

Blood. 2004 Mar 15;103(6):2284-90. Epub 2003 Nov 26.

PMID:
14645009
26.

Determination and differentiation of surface and bound water in drug substances by near infrared spectroscopy.

Zhou GX, Ge Z, Dorwart J, Izzo B, Kukura J, Bicker G, Wyvratt J.

J Pharm Sci. 2003 May;92(5):1058-65.

PMID:
12712426
27.

BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations.

Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F.

Oncogene. 2002 Dec 9;21(56):8652-67. Review.

28.

A novel MLL/AF4 fusion gene lacking the AF4 transactivating domain in infant acute lymphoblastic leukemia.

Pane F, Intrieri M, Izzo B, Quintarelli C, Vitale D, Migliorati R, Sebastio L, Salvatore F.

Blood. 2002 Dec 1;100(12):4247-8. No abstract available.

PMID:
12433702
29.

Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.

Di Noto R, Pane F, Camera A, Luciano L, Barone M, Lo Pardo C, Boccuni P, Intrieri M, Izzo B, Villa MR, Macrí M, Rotoli B, Sacchetti L, Salvatore F, Del Vecchio L.

Leukemia. 2001 Oct;15(10):1641-9.

30.

Intrauterine device for contraception in dogs.

Volpe P, Izzo B, Russo M, Iannetti L.

Vet Rec. 2001 Jul 21;149(3):77-9.

PMID:
11497398
31.

Male pseudo-hermaphroditism in a dog: a clinical case.

Volpe P, Izzo B, Di Meo GP, Perucatti A, Iannuzzi L.

Vet Rec. 2000 Apr 29;146(18):532-3. No abstract available.

PMID:
11321217
32.

Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.

Camera A, Pezzullo L, Villa MR, Luciano L, Pane F, Izzo B, Boccuni P, Di Noto R, Del Vecchio L, Salvatore F, Rotoli B.

Haematologica. 2000 May;85(5):496-501.

Supplemental Content

Support Center